How can DKB and tobramycin be inactivated on two different sites by the same enzyme?
D000900:Anti-Bacterial Agents / Q000378:metabolism*; D002474:Cell-Free System; D055598:Chemical Phenomena; D002621:Chemistry; D003982:Dibekacin / Q000378:metabolism*; D007612:Kanamycin / Q000031:analogs & derivatives*; D008968:Molecular Conformation; D009713:Nucleotidyltransferases / Q000378:metabolism*; D013211:Staphylococcus aureus / Q000201:enzymology*; D013379:Substrate Specificity; D014031:Tobramycin / Q000378:metabolism*
D000900:Anti-Bacterial Agents; D003982:Dibekacin; D007612:Kanamycin; D009713:Nucleotidyltransferases; D014031:Tobramycin